Intracytoplasmic phosphorylation sites of Tac antigen (p55) are not essential for the conformation, function, and regulation of the human interleukin 2 receptor - PubMed (original) (raw)
Intracytoplasmic phosphorylation sites of Tac antigen (p55) are not essential for the conformation, function, and regulation of the human interleukin 2 receptor
M Hatakeyama et al. Proc Natl Acad Sci U S A. 1986 Dec.
Abstract
Tac antigen, the receptor for human interleukin 2 (IL-2), contains in its intracytoplasmic region a serine residue (Ser-247) that is seemingly the predominant site of protein kinase C-mediated phosphorylation. A number of studies on growth factor receptors have suggested the importance of phosphorylation in receptor structure, function, and regulation. In this study, we generated site-directed mutations in the Tac antigen cDNA to generate mutant receptors in which Ser-247 or Thr-250, a probable site of minor phosphorylation, was replaced with another amino acid that is not accessible to phosphorylation. Study of the expression of these mutant genes in a T-lymphoid cell line has provided no evidence as to the essential role of the above-mentioned residues in determining the degree of receptor affinity, its ability for signal transduction, and phorbol ester-mediated regulation of the receptor. Our results strongly suggest the existence of an IL-2 receptor "complex" in which the Tac antigen is associated with another molecule(s) that is involved in receptor structure, function, and regulation.
Similar articles
- Properties of human interleukin-2 receptors expressed on non-lymphoid cells by cDNA transfection.
Sabe H, Kondo S, Shimizu A, Tagaya Y, Yodoi J, Kobayashi N, Hatanaka M, Matsunami N, Maeda M, Noma T, et al. Sabe H, et al. Mol Biol Med. 1984 Dec;2(6):379-96. Mol Biol Med. 1984. PMID: 6443699 Review. - Phosphorylation of the human interleukin-2 receptor and a synthetic peptide identical to its C-terminal, cytoplasmic domain.
Gallis B, Lewis A, Wignall J, Alpert A, Mochizuki DY, Cosman D, Hopp T, Urdal D. Gallis B, et al. J Biol Chem. 1986 Apr 15;261(11):5075-80. J Biol Chem. 1986. PMID: 3082877 - Association of protein kinase C activation with IL 2 receptor expression.
Farrar WL, Ruscetti FW. Farrar WL, et al. J Immunol. 1986 Feb 15;136(4):1266-73. J Immunol. 1986. PMID: 3003192 - The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation.
Waldmann TA. Waldmann TA. Environ Health Perspect. 1987 Nov;75:11-5. doi: 10.1289/ehp.877511. Environ Health Perspect. 1987. PMID: 2891501 Free PMC article. Review.
Cited by
- Dysregulation of growth factor-receptor system in cellular transformation.
Hatakeyama M, Taniguchi T. Hatakeyama M, et al. Jpn J Cancer Res. 1988 Aug;79(8):885-901. doi: 10.1111/j.1349-7006.1988.tb00052.x. Jpn J Cancer Res. 1988. PMID: 3141325 Free PMC article. Review. No abstract available. - The integrity of the conserved 'WS motif' common to IL-2 and other cytokine receptors is essential for ligand binding and signal transduction.
Miyazaki T, Maruyama M, Yamada G, Hatakeyama M, Taniguchi T. Miyazaki T, et al. EMBO J. 1991 Nov;10(11):3191-7. doi: 10.1002/j.1460-2075.1991.tb04881.x. EMBO J. 1991. PMID: 1915291 Free PMC article. - Expression and modulation of cell surface determinants on human adult and neonatal monocytes.
Marwitz PA, Van Arkel-Vigna E, Rijkers GT, Zegers BJ. Marwitz PA, et al. Clin Exp Immunol. 1988 May;72(2):260-6. Clin Exp Immunol. 1988. PMID: 2457464 Free PMC article. - Interleukin-2 receptor signaling in regulatory T cell development and homeostasis.
Burchill MA, Yang J, Vang KB, Farrar MA. Burchill MA, et al. Immunol Lett. 2007 Nov 30;114(1):1-8. doi: 10.1016/j.imlet.2007.08.005. Epub 2007 Sep 14. Immunol Lett. 2007. PMID: 17936914 Free PMC article. Review. - Ab-IL2 fusion proteins mediate NK cell immune synapse formation by polarizing CD25 to the target cell-effector cell interface.
Gubbels JA, Gadbaw B, Buhtoiarov IN, Horibata S, Kapur AK, Patel D, Hank JA, Gillies SD, Sondel PM, Patankar MS, Connor J. Gubbels JA, et al. Cancer Immunol Immunother. 2011 Dec;60(12):1789-800. doi: 10.1007/s00262-011-1072-9. Epub 2011 Jul 27. Cancer Immunol Immunother. 2011. PMID: 21792658 Free PMC article.
References
- J Immunol. 1986 Jun 1;136(11):3968-76 - PubMed
- Eur J Biochem. 1982 Dec 15;129(2):389-93 - PubMed
- J Clin Invest. 1985 Aug;76(2):446-53 - PubMed
- J Biol Chem. 1984 Jul 10;259(13):8545-9 - PubMed
- Methods Enzymol. 1983;100:468-500 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources